Abstract
Background: Systemic sclerosis (scleroderma; SSc) is a rare autoimmune connective tissue disease. Functional impairment of hands is common. The Scleroderma Patient-centered Intervention Network (SPIN)-HAND trial compared effects of offering access to an online self-guided hand exercise program to usual care on hand function (primary) and functional health outcomes (secondary) in people with SSc with at least mild hand function limitations. Methods: The pragmatic, two-arm, parallel-group cohort multiple randomized controlled trial was embedded in the SPIN Cohort. Cohort participants with Cochin Hand Function Scale (CHFS) scores ≥ 3 and who indicated interest in using the SPIN-HAND Program were randomized (3:2 ratio) to an offer of program access or to usual care (targeted N = 586). The SPIN-HAND program consists of 4 modules that address (1) thumb flexibility and strength; (2) finger bending; (3) finger extension; and (4) wrist flexibility and strength. The primary outcome analysis compared CHFS scores 3 months post-randomization between participants offered versus not offered the program. Secondary outcomes were CHFS scores 6 months post-randomization and functional health outcomes (Patient-Reported Outcomes Measurement Information System profile version 2.0 domain scores) 3 and 6 months post-randomization. Results: In total, 466 participants were randomized to intervention offer (N = 280) or usual care (N = 186). Of 280 participants offered the intervention, 170 (61%) consented to access the program. Of these, 117 (69%) viewed at least one hand exercise instruction video and 77 (45%) logged into the program website at least 3 times. In intent-to-treat analyses, CHFS scores were 1.2 points lower (95% CI − 2.8 to 0.3) for intervention compared to usual care 3 months post-randomization and 0.1 points lower (95% CI − 1.8 to 1.6 points) 6 months post-randomization. There were no statistically significant differences in other outcomes. Conclusion: The offer to use the SPIN-HAND Program did not improve hand function. Low offer uptake, program access, and minimal usage among those who accessed the program limited our ability to determine if using the program would improve function. To improve engagement, the program could be tested in a group format or as a resource to support care provided by a physical or occupational therapist. Trial registration: NCT03419208. Registered on February 1, 2018.
Original language | English (US) |
---|---|
Article number | 994 |
Journal | Trials |
Volume | 23 |
Issue number | 1 |
DOIs | |
State | Published - Dec 2022 |
Funding
The SPIN team is dedicating the SPIN-HAND program to the memory of Dr. Serge Poiraudeau, who led the SPIN-HAND project team, along with Dr. Luc Mouthon. Dr. Poiraudeau cared deeply for the quality of life and well-being of people living with scleroderma, and without his leadership and dedication, the SPIN-HAND Program would not have been possible. The SPIN Investigators: Richard S. Henry, Jewish General Hospital, Montreal, Quebec, Canada; Susan J. Bartlett, McGill University, Montreal, Quebec, Canada; Catherine Fortun\u00E9, Ottawa Scleroderma Support Group, Ottawa, Ontario, Canada; Karen Gottesman, National Scleroderma Foundation, Los Angeles, California, USA; Genevi\u00E8ve Guillot, Scl\u00E9rodermie Qu\u00E9bec, Longueuil, Quebec, Canada; Laura K. Hummers, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Amanda Lawrie-Jones, Scleroderma Australia and Scleroderma Victoria, Melbourne, Victoria, Australia. The SPIN-HAND trial was funded by the Arthritis Society (#SOG-16\u2013380) and the Canadian Institutes of Health Research (PJT-149073). The Scleroderma Patient-centered Intervention Network (SPIN) has received funding for its core activities, including the SPIN Cohort, from the Canadian Institutes of Health Research, the Arthritis Society, the Lady Davis Institute for Medical Research of the Jewish General Hospital, Montreal, Canada, the Jewish General Hospital Foundation, Montreal, Canada, McGill University, Montreal, Canada, the Scleroderma Society of Ontario, Scleroderma Canada, Scl\u00E9rodermie Qu\u00E9bec, Scleroderma Manitoba, Scleroderma Atlantic, the Scleroderma Association of BC, Scleroderma SASK, Scleroderma Australia, Scleroderma New South Wales, Scleroderma Victoria, and Scleroderma Queensland. Dr. Thombs was supported by a Tier 1 Canada Research Chair. Dr. Levis was supported by a Fonds de recherche du Qu\u00E9bec \u2013 Sant\u00E9 (FRQ-S) Postdoctoral Training Fellowship.
Keywords
- Cohort multiple RCT
- Occupational therapy
- Physical therapy
- Randomized controlled trial
- Scleroderma, Systemic
- Systemic sclerosis
- Tele-rehabilitation
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Pharmacology (medical)